These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 7081979

  • 1. Minimal nephrotoxicity with cephalosporin-aminoglycoside combinations in patients with neoplastic disease.
    Brown AE, Quesada O, Armstrong D.
    Antimicrob Agents Chemother; 1982 Apr; 21(4):592-4. PubMed ID: 7081979
    [Abstract] [Full Text] [Related]

  • 2. Nephrotoxicity of aminoglycosides and cephalosporins in combination.
    Rankin GO, Sutherland CH.
    Adverse Drug React Acute Poisoning Rev; 1989 Apr; 8(2):73-88. PubMed ID: 2672726
    [Abstract] [Full Text] [Related]

  • 3. Considerations regarding clinical safety and tolerability of antibiotics in serious and nosocomial infections.
    Smith CR.
    Clin Ther; 1981 Apr; 4 Suppl A():133-45. PubMed ID: 7034939
    [Abstract] [Full Text] [Related]

  • 4. Nephrotoxicity of aminoglycosides, polypeptides and cephalosporins in cancer patients.
    Krcméry V, Fuchsberger P, Gocár M, Salát T, Bodnárová J, Sobota R, Koza I, Svec J.
    Chemotherapy; 1991 Apr; 37(4):287-91. PubMed ID: 1790727
    [Abstract] [Full Text] [Related]

  • 5. Cephalosporin-aminoglycoside synergistic nephrotoxicity: fact or fiction?
    Mannion JC, Bloch R, Popovich NG.
    Drug Intell Clin Pharm; 1981 Apr; 15(4):248-56. PubMed ID: 7023896
    [Abstract] [Full Text] [Related]

  • 6. Relationship between aminoglycoside-induced nephrotoxicity and auditory toxicity.
    Smith CR, Lipsky JJ, Lietman PS.
    Antimicrob Agents Chemother; 1979 Jun; 15(6):780-2. PubMed ID: 475363
    [Abstract] [Full Text] [Related]

  • 7. Antibiotic combination-associated nephrotoxicity in granulocytopenic patients with cancer.
    Wade JC, Schimpff SC, Wiernik PH.
    Arch Intern Med; 1981 Dec; 141(13):1789-93. PubMed ID: 6797359
    [Abstract] [Full Text] [Related]

  • 8. Do cephalosporins potentiate or antagonize aminoglycoside nephrotoxicity?
    Marsh FP.
    J Antimicrob Chemother; 1978 Mar; 4(2):103-6. PubMed ID: 649529
    [No Abstract] [Full Text] [Related]

  • 9. Comment on cephalosporin-aminoglycoside toxicity.
    Hopefl AW.
    Drug Intell Clin Pharm; 1981 Sep; 15(9):697-9. PubMed ID: 7274064
    [No Abstract] [Full Text] [Related]

  • 10. Do cephalosporins potentiate or antagonize aminoglycoside nephrotoxicity?
    March FP.
    J Antimicrob Chemother; 1978 Nov; 4(6):577-8. PubMed ID: 711654
    [No Abstract] [Full Text] [Related]

  • 11. Clinical evaluation of urinary N-acetyl-beta-D-glucosaminidase activity in patients receiving aminoglycoside and cephalosporin drugs.
    Naruse T, Hirokawa N, Oike S, Maekawa T.
    Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):313-29. PubMed ID: 7221185
    [Abstract] [Full Text] [Related]

  • 12. Empiric therapy of febrile granulocytopenic patients.
    Hopefl AW.
    Am J Hosp Pharm; 1979 Feb; 36(2):178-87. PubMed ID: 369364
    [Abstract] [Full Text] [Related]

  • 13. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG, Giotis ND, Baliatsa DV, Ioannidis JP.
    Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
    [Abstract] [Full Text] [Related]

  • 14. Cephalosporin-induced nephrotoxicity: does it exist?
    Zhanel GG.
    DICP; 1990 Mar; 24(3):262-5. PubMed ID: 2180220
    [Abstract] [Full Text] [Related]

  • 15. Comparative nephrotoxicity of gentamicin and tobramycin: pharmacokinetic and clinical studies in 201 patients.
    Schentag JJ, Plaut ME, Cerra FB.
    Antimicrob Agents Chemother; 1981 May; 19(5):859-66. PubMed ID: 7294770
    [Abstract] [Full Text] [Related]

  • 16. Lack of nephrotoxicity in pediatric patients receiving concurrent vancomycin and aminoglycoside therapy.
    Nahata MC.
    Chemotherapy; 1987 May; 33(4):302-4. PubMed ID: 3608631
    [Abstract] [Full Text] [Related]

  • 17. Controlled comparison of gentamicin and tobramycin nephrotoxicity.
    Matzke GR, Lucarotti RL, Shapiro HS.
    Am J Nephrol; 1983 May; 3(1):11-7. PubMed ID: 6340504
    [Abstract] [Full Text] [Related]

  • 18. Risk factors for nephrotoxicity in patients treated with aminoglycosides.
    Moore RD, Smith CR, Lipsky JJ, Mellits ED, Lietman PS.
    Ann Intern Med; 1984 Mar; 100(3):352-7. PubMed ID: 6364908
    [Abstract] [Full Text] [Related]

  • 19. Clinical and pharmacokinetic characteristics of aminoglycoside nephrotoxicity in 201 critically ill patients.
    Schentag JJ, Cerra FB, Plaut ME.
    Antimicrob Agents Chemother; 1982 May; 21(5):721-6. PubMed ID: 7103453
    [Abstract] [Full Text] [Related]

  • 20. Aminoglycoside-induced nephrotoxicity studied by proton magnetic resonance spectroscopy of urine.
    Tzovaras V, Tsimihodimos V, Kostara C, Mitrogianni Z, Elisaf M.
    Nephrol Dial Transplant; 2011 Oct; 26(10):3219-24. PubMed ID: 21372252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.